InsidersTradesSigma
Explore the full record of transactions filed by Rachman Ilya M, Chairman & CEO. Director active across 1 companies, notably Immix Biopharma, Inc.. In total, 2 disclosures have been recorded. Total volume traded: €22k. The latest transaction was filed on 20 December 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Ilya M. Rachman is the CEO and Chairman of Immix Biopharma, Inc., a biopharmaceutical company. He oversees the strategic direction of the company and manages its operations. His expertise in the biopharmaceutical sector allows him to lead initiatives aimed at developing new treatments and improving patient outcomes.